- Home
- HMY vs RDNT Comparison
HMY vs RDNT Comparison
Compare HMY & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- RDNT
- Stock Information
- Founded
- HMY 1950
- RDNT 1985
- Country
- HMY South Africa
- RDNT United States
- Employees
- HMY N/A
- RDNT N/A
- Industry
- HMY Precious Metals
- RDNT Medical Specialities
- Sector
- HMY Basic Materials
- RDNT Health Care
- Exchange
- HMY Nasdaq
- RDNT Nasdaq
- Market Cap
- HMY 5.4B
- RDNT 6.0B
- IPO Year
- HMY N/A
- RDNT 1986
- Fundamental
- Price
- HMY $8.43
- RDNT $72.16
- Analyst Decision
- HMY Sell
- RDNT Strong Buy
- Analyst Count
- HMY 3
- RDNT 4
- Target Price
- HMY $6.60
- RDNT $84.75
- AVG Volume (30 Days)
- HMY 4.7M
- RDNT 515.2K
- Earning Date
- HMY 01-01-0001
- RDNT 11-10-2024
- Dividend Yield
- HMY 1.54%
- RDNT N/A
- EPS Growth
- HMY 75.55
- RDNT N/A
- EPS
- HMY 0.75
- RDNT N/A
- Revenue
- HMY $3,362,293,253.00
- RDNT $1,772,946,000.00
- Revenue This Year
- HMY $14.40
- RDNT $14.93
- Revenue Next Year
- HMY $5.26
- RDNT $8.83
- P/E Ratio
- HMY $11.33
- RDNT N/A
- Revenue Growth
- HMY 24.56
- RDNT 12.20
- 52 Week Low
- HMY $5.40
- RDNT $33.44
- 52 Week High
- HMY $12.29
- RDNT $93.65
- Technical
- Relative Strength Index (RSI)
- HMY 37.79
- RDNT 34.14
- Support Level
- HMY $8.25
- RDNT $78.42
- Resistance Level
- HMY $9.71
- RDNT $79.45
- Average True Range (ATR)
- HMY 0.30
- RDNT 2.66
- MACD
- HMY -0.04
- RDNT -1.44
- Stochastic Oscillator
- HMY 12.33
- RDNT 7.20
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.